- Stage
- In committee
- Started in
- Senate
- Sponsors
- 5
- Latest action
- Jun 23, 2026
What it does
The PASTEUR Act of 2026 would establish a program under the Public Health Service Act to develop innovative antimicrobial drugs targeting urgent or serious antibiotic-resistant pathogens by entering into contracts with drug sponsors. These contracts would require sponsors to ensure commercial availability, maintain supply chains, report resistance data, promote appropriate use, and follow environmental best practices, in exchange for annual federal payments ranging from $75 million to $300 million (adjusted for inflation), reduced by the drug’s net U.S. revenue. The bill aims to stimulate research, ensure appropriate use of lifesaving medicines, maintain high medical care standards,…
No official summary is available here. This one was written by AI from the bill’s text.
Where it stands
Introduced (Done)
Committee (Current step)
Floor (Not started)
Law (Not started)
What moved
Who is involved
Sponsors
The lawmakers who put their names on it, lead sponsors first.
In the news
Reporting that may mention this subject. Possible matches are labeled.
Loading coverage…
Where it goes next
While a bill can still move, the questions are about people and money.